1Sheppard P,Kindsvogel W,Xu W et al.IL-28,IL-29 and their class II cytokine receptor IL-28R[J].Nat Immunol,2003,4(1):63.
2Kotenko S V,Gallagher G,Baurin V V,et al.IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex[J].Nat Immunol,2003,4(1):69.
3Ferrantini M,Capone I,Belardelli F.Interferon-a and cancer:Mechanisms of action and new perspectives of clinical use[J].Biochimie,2007,89 (6～7):884.
4Renauld J C.ClassⅡ cytokine receptors and their ligands:key antiviral and inflammatory modulators[J].Nature Rev Immunol,2003,3(8):667.
5Ank N,West H,Bartholdy C,et al.Lambda interferon (IFN-lambda),a type III IFN,is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo[J].J Virol,2006,80(9):4501.
6Dumoutier L,Lejeune D,Hor D,et al.Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1,STAT2 and STAT3[J].Biochem J,2003,370(Pt 2):391.
7Dumoutier L,Tounsi A,Michiels T,et al.Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1:similarities with type I interferon signaling[J].J Biol Chem,2004,279(31):32269.
9Zhou Z,Hamming O J,Ank N,et al.Type Ⅲ Interferon (IFN) Induces a Type Ⅰ IFN-Like Response in a Restricted Subset of Cells through Signaling Pathways Involving both the Jak-STAT Pathway and the Mitogen-Activated Protein Kinases[J].J Virol.2007,81(14):7749.
1[1]Sheppard P, Kindsvogel W, Xu W et al. IL-28, IL-29 and their class Ⅱ cytokine receptor IL-28R[J]. Nature Immunol, 2003,4(1): 63-68.
2[2]Kotenko SV, Gallagher G, Baurin VV et al. IFN-λs mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex [ J ].Nature Immunol, 2003,4(1 ): 69-77.
3[3]LaFleur DW , Nardelli B, Tsareva T et al. Interferon-kappa, a novel type I interferon expressed in human keratinocytes[ J ]. J Biol Chem,2001, 276(43) :39765-39771.
5[5]Kotenko SV. Tne family of IL10-related cytokines and their and their receptors: related, but to what extent? [ J ] Cytokine Growth Factor Rev, 20]02,13(3): 223-240.
6[6]Dumoutier L, Renauld JC. Viral and cellular interleukin-10(IL-l0)-related cytokines: from structures to functions [ J ]. Eur Cytokine Netw, 2002, 13(1): 5-15.
7[7]Renauld JC. Class Ⅱ cytokine receptors and their ligands: key antiviral and inflammatory modulators[J]. Nature Rev Immunol, 2003,3(8):667 -676.
8[9]Vilcek J. Novelinterferons[J]. Nature Immunol, 2003, 4(1) :8-9.
